|
1
|
Moyzis RK, Buckingham JM, Cram LS, Dani M,
Deaven LL, Jones MD, Meyne J, Ratliff RL and Wu JR: A highly
conserved repetitive DNA sequence, (TTAGGG)n, present at
the telomeres of human chromosomes. Proc Natl Acad Sci USA.
85:6622–6626. 1988. View Article : Google Scholar
|
|
2
|
de Lange T: Shelterin: The protein complex
that shapes and safeguards human telomeres. Genes Dev.
19:2100–2110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shay JW: Telomerase therapeutics:
Telomeres recognized as a DNA damage signal: Commentary re: K.
Kraemer et al, antisense-mediated hTERT inhibition specifically
reduces the growth of human bladder cancer cells. Clin Cancer Res.
9:3794–3800. 2003.
Clin Cancer Res. 9:3521–3525. 2003.
|
|
4
|
Wright WE, Piatyszek MA, Rainey WE, Byrd W
and Shay JW: Telomerase activity in human germline and embryonic
tissues and cells. Dev Genet. 18:173–179. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim NW, Piatyszek MA, Prowse KR, Harley
CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay
JW: Specific association of human telomerase activity with immortal
cells and cancer. Science. 266:2011–2015. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Low KC and Tergaonkar V: Telomerase:
Central regulator of all of the hallmarks of cancer. Trends Biochem
Sci. 38:426–434. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ghosh A, Saginc G, Leow SC, Khattar E,
Shin EM, Yan TD, Wong M, Zhang Z, Li G, Sung WK, et al: Telomerase
directly regulates NF-κB-dependent transcription. Nat Cell Biol.
14:1270–1281. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ding D, Xi P, Zhou J, Wang M and Cong YS:
Human telomerase reverse transcriptase regulates MMP expression
independently of telomerase activity via NF-κB-dependent
transcription. FASEB J. 27:4375–4383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park JI, Venteicher AS, Hong JY, Choi J,
Jun S, Shkreli M, Chang W, Meng Z, Cheung P, Ji H, et al:
Telomerase modulates Wnt signalling by association with target gene
chromatin. Nature. 460:66–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Listerman I, Gazzaniga FS and Blackburn
EH: An investigation of the effects of the core protein telomerase
reverse transcriptase on Wnt signaling in breast cancer cells. Mol
Cell Biol. 34:280–289. 2014. View Article : Google Scholar :
|
|
11
|
Li Y and Tergaonkar V: Noncanonical
functions of telomerase: Implications in telomerase-targeted cancer
therapies. Cancer Res. 74:1639–1644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Autexier C and Lue NF: The structure and
function of telomerase reverse transcriptase. Annu Rev Biochem.
75:493–517. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Seimiya H, Sawada H, Muramatsu Y, Shimizu
M, Ohko K, Yamane K and Tsuruo T: Involvement of 1-3-3 proteins in
nuclear localization of telomerase. EMBO J. 19:2652–2661. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Banik SS, Guo C, Smith AC, Margolis SS,
Richardson DA, Tirado CA and Counter CM: C-terminal regions of the
human telomerase catalytic subunit essential for in vivo enzyme
activity. Mol Cell Biol. 22:6234–6246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang JJ, Lin MC, Bai YX, Jing DD, Wong
BC, Han SW, Lin J, Xu B, Huang CF and Kung HF: Ectopic expression
of a COOH-terminal fragment of the human telomerase reverse
transcriptase leads to telomere dysfunction and reduction of growth
and tumorigenicity in HeLa cells. Cancer Res. 62:3226–3232.
2002.PubMed/NCBI
|
|
16
|
Ng SS, Gao Y, Chau DH, Li GH, Lai LH,
Huang PT, Huang CF, Huang JJ, Chen YC, Kung HF, et al: A novel
glioblastoma cancer gene therapy using AAV-mediated long-term
expression of human TERT C-terminal polypeptide. Cancer Gene Ther.
14:561–572. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao Y, Ng SS, Chau DH, Yao H, Yang C, Man
K, Huang PT, Huang C, Huang JJ, Kung HF, et al: Development of
recombinant adeno-associated virus and adenovirus cocktail system
for efficient hTERTC27 polypeptide-mediated cancer gene therapy.
Cancer Gene Ther. 15:723–732. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He L, Gong HX, Li XP, Wang YD, Li Y, Huang
JJ, Xie D, Kung HF and Peng Y: Inhibition of hepatocellular
carcinoma growth by adenovirus-mediated expression of human
telomerase reverse transcriptase COOH-27 terminal polypeptide in
mice. Oncol Lett. 6:748–752. 2013.PubMed/NCBI
|
|
19
|
Huo L, Yao H, Wang X, Wong GW, Kung HF and
Lin MC: Inhibition of melanoma growth by subcutaneous
administration of hTERTC27 viral cocktail in C57BL/6 mice. PLoS
One. 5:e127052010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin G, Chen Q, Yu S, Lin S, Yao H, Ding Z,
Chen S, Lin MC and Wang X: Overexpression of human telomerase
reverse transcriptase C-terminal polypeptide sensitizes HeLa cells
to 5-fluorouracil-induced growth inhibition and apoptosis. Mol Med
Rep. 9:279–284. 2014.
|
|
21
|
Li HW, Gao YX, Raizada MK and Sumners C:
Intronic enhancement of angiotensin II type 2 receptor transgene
expression in vitro and in vivo. Biochem Biophys Res Commun.
336:29–35. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yoon JW, Lee JS, Kim BM, Ahn J and Yang
KM: Catechin-7-O-xyloside induces apoptosis via endoplasmic
reticulum stress and mitochondrial dysfunction in human non-small
cell lung carcinoma H1299 cells. Oncol Rep. 31:314–320. 2014.
|
|
23
|
Damm K, Hemmann U, Garin-Chesa P, Hauel N,
Kauffmann I, Priepke H, Niestroj C, Daiber C, Enenkel B, Guilliard
B, et al: A highly selective telomerase inhibitor limiting human
cancer cell proliferation. EMBO J. 20:6958–6968. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu XQ, Huang C, He X, Tian YY, Zhou DX, He
Y, Liu XH and Li J: Feedback regulation of telomerase reverse
transcriptase: new insight into the evolving field of telomerase in
cancer. Cell Signal. 25:2462–2468. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu W, Zhang G, Zhang R, Flores LG II,
Huang Q, Gelovani JG and Li C: Tumor site-specific silencing of
NF-kappaB p65 by targeted hollow gold nanosphere-mediated
photothermal transfection. Cancer Res. 70:3177–3188. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Xing D, Chen Q and Chen WR:
Enhancement of chemotherapeutic agent-induced apoptosis by
inhibition of NF-kappaB using ursolic acid. Int J Cancer.
127:462–473. 2010.
|
|
27
|
Juneja M, Vanam U, Paranthaman S,
Bharathan A, Keerthi VS, Reena JK, Rajaram R, Rajasekharan KN and
Karunagaran D: 4-Amino-2-arylamino-5-indoloyl/cinnamoythiazoles,
analogs of topsentin-class of marine alkaloids, induce apoptosis in
HeLa cells. Eur J Med Chem. 63:474–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Harley CB, Futcher AB and Greider CW:
Telomeres shorten during ageing of human fibroblasts. Nature.
345:458–460. 1990. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hastie ND, Dempster M, Dunlop MG, Thompson
AM, Green DK and Allshire RC: Telomere reduction in human
colorectal carcinoma and with ageing. Nature. 346:866–868. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Counter CM, Avilion AA, LeFeuvre CE,
Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere
shortening associated with chromosome instability is arrested in
immortal cells which express telomerase activity. EMBO J.
11:1921–1929. 1992.PubMed/NCBI
|
|
31
|
Hahn WC, Stewart SA, Brooks MW, York SG,
Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M and
Weinberg RA: Inhibition of telomerase limits the growth of human
cancer cells. Nat Med. 5:1164–1170. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zuo QP, Liu SK, Li ZJ, Li B, Zhou YL, Guo
R and Huang LH: NF-kappaB p65 modulates the telomerase reverse
transcriptase in the HepG2 hepatoma cell line. Eur J
Pharmacol. 672:113–120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Akiyama M, Hideshima T, Hayashi T, Tai YT,
Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC and
Anderson KC: Nuclear factor-kappaB p65 mediates tumor necrosis
factor alpha-induced nuclear translocation of telomerase reverse
transcriptase protein. Cancer Res. 63:18–21. 2003.PubMed/NCBI
|
